MDSpire - Takeaway
From the Journals

Molecular Test Doubles Detection of Bile Duct Cancer

According to recent research, a new molecular test could detect bile duct cancer with twice the sensitivity of the standard test, giving physicians a more accurate picture of a patient’s diagnosis. 

Share

  • 1

    BiliSeq significantly improves bile duct cancer detection.

  • 2

    Sensitivity of BiliSeq is around 82%.

  • 3

    It is not a general screening test but targets specific patient groups.

  • 4

    The test provides treatment-relevant genetic information.

  • 5

    It holds promise for reducing unnecessary repeat testing.

  • 6

    Study included over 2,000 patients in the US.

  • 7

    Collaboration with institutions enhances the study's applicability.

Original Source(s)

Molecular Test Doubles Detection of Bile Duct Cancer

  • by The ASCO Post Staff

  • March 31, 2026

Related Content

New Histology Signal in Crohn’s

Distinct lymphoid structures identified in fibrostenosing Crohn’s specimens

  • March 26, 2026

  • 2 min
ESD with DiLumen IgE; Grasp and Final Cut

ESD can be especially challenging without traction.  In this video Dr. Molham Abdulsamad of Geisinger Health demonstrates how he can greatly extend retraction and broadly expose and dissect the last attachments at the end of the ESD procedure.

  • March 24, 2026

ESD with DiLumen IgE; Grasp, Lift and Cut 3

ESD can be especially challenging without traction.  In this video Dr. Molham Abdulsamad of Geisinger Health demonstrates that with Lumendi’s IgE Grasper he can regrasp and reposition traction during the procedure to maximize submucosal exposure during ESD.

  • March 24, 2026